-

SHAREHOLDER ALERT: Robbins LLP Informs Investors of Class Action Lawsuit Against TMC The Metals Company Inc. (TMC) f/k/a Sustainable Opportunities Acquisition Corp.

SAN DIEGO--(BUSINESS WIRE)--Shareholder rights law firm Robbins LLP informs investors that a class action was filed on behalf of all persons and entities that purchased TMC the metals company (NASDAQ: TMC) f/k/a Sustainable Opportunities Acquisition Corp. ("SOAC") securities between March 4, 2021 and October 5, 2021, alleging violations of the Securities Exchange Act of 1934. TMC purports to be a deep-sea minerals exploration company focused on the collection, processing, and refining of polymetallic nodules found on the seafloor of the CCZ of the Eastern Pacific Ocean. The Company's primary assets are three exploration licenses.

If you suffered a loss due to TMC the metals company Inc.'s misconduct, click here.

TMC the metals company Inc. (TMC) Misled Investors Regarding its Business Prospects

According to the complaint, TMC was formed when DeepGreen combined with SOAC, a special purpose acquisition corporation "with a dedicated ESG focus and deep operational and capital market capabilities in the energy and resource sectors." A March 4, 2021, press release stated that "[t]he transaction includes an upsized US$330 million fully committed common stock Private Investment in Public Equity ("PIPE") at US $10.00 per share, anchored by an international consortium of strategic and institutional investors…" The press release also noted that DeepGreen "offers a real, scalable solution to the raw metals problem, at a low production cost and with a significant reduction in the ESG footprint of metals."

On September 13, 2021, Bloomberg published an article revealing that "two unidentified investors [failed] to provide funds comprising two-thirds of TMC's $330 million PIPE…" and questioning TMC's "green credentials." On this news, TMC's shares fell $2.45 over the next two trading days to close at $10.00 on September 15, 2021. Then, on October 6, 2021, Bonitas Research reported: (i) that TMC had overpaid on its exploration licenses to potential undisclosed insiders; (ii) the Company had artificially inflated exploration expenses by more than 100% in order to mislead investors about the scale of its operations; (iii) there are reasons to question the Company's ownership claim of its Nauru Ocean Resources license; and (iv) the Company has a history of affiliating with bad actors. On this news, the Company's stock dropped 7%, to close at $4.14 per share on October 6, 2021. The stock now trades just over $3.00.

If you purchased shares of TMC the metals company Inc. (TMC) securities between March 4, 2021 and October 5, 2021, you have until December 27, 2021, to ask the court to appoint you lead plaintiff for the class.

All representation is on a contingency fee basis. Shareholders pay no fees or expenses.

Contact us to learn more:

Aaron Dumas
(800) 350-6003
adumas@robbinsllp.com
Shareholder Information Form

About Robbins LLP: A recognized leader in shareholder rights litigation, the attorneys and staff of Robbins LLP have been dedicated to helping shareholders recover losses, improve corporate governance structures, and hold company executives accountable for their wrongdoing since 2002. To be notified if a class action against TMC the metals company Inc. settles or to receive free alerts when corporate executives engage in wrongdoing, sign up for Stock Watch today.

Attorney Advertising. Past results do not guarantee a similar outcome.

Contacts

Aaron Dumas
Robbins LLP
5040 Shoreham Place
San Diego, CA 92122
adumas@robbinsllp.com
(800) 350-6003
www.robbinsllp.com

More News From Robbins LLP

Robbins LLP Urges GOSS Stockholders to Contact the Firm for Information About the Class Action Against Gossamer Bio, Inc.

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP reminds stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Gossamer Bio, Inc. (NASDAQ: GOSS) securities between June 16, 2025 and February 20, 2026. Gossamer is a clinical stage biopharmaceutical company focused on the development and commercialization of seralutinib for the treatment of pulmonary hypertension (PH) associated with interstitial lung disease.For more information, submit a form, email att...

Robbins LLP Urges IBRX Stockholders to Contact the Firm for Information About the Class Action Against ImmunityBio, Inc.

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP reminds stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired ImmunityBio, Inc. (NASDAQ: IBRX) securities between January 19, 2026 and March 25, 2026. ImmunityBio is a biotechnology company and ANKTIVA is the Company's lead biologic product. For more information, submit a form, email attorney Aaron Dumas, Jr., or give us a call at (800) 350-6003. What is the class period? January 19, 2026 – March 25, 202...

Robbins LLP Reminds ALDX Investors of the Pending Class Action Lawsuit; Harmed Investors Should Contact the Firm for Information About Leading the Case Against Aldeyra Therapeutics, Inc.

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP reminds stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Aldeyra Therapeutics, Inc. (NASDAQ: ALDX) securities between November 3, 2023 and March 16, 2026. Defendant Aldeyra describes itself as a “biotechnology company devoted to discovering innovative therapies designed to treat immune-mediated diseases.” Pertinent to this action is reproxalap, which is a novel reactive aldehyde species (RASP) inhib...
Back to Newsroom